Phase 1 trial finds high dose of malaria monoclonal antibody is safe, elicits immune response - CIDRAP

Phase 1 trial finds high dose of malaria monoclonal antibody is safe, elicits immune response  CIDRAP ...

Phase,1,trial,finds,high,dose,of,malaria,monoclonal,antibody